The SRC proto-oncogene has been demonstrated to activate NADPH oxidases NOX1-, NOX3-, NOX4-, and NOX5-induced O2•− production in cancer models (87, 105, 107, 171) and to increase mutant SOD1 aggregate formation in ALS. This evidence concerns the gene FMO5 and cancer.